Professional History

Board Certification

• Clinical Genetics - American Board of Medical Genetics and Genomics
  
• Medical Biochemical Genetics - American Board of Medical Genetics and Genomics
  
• Pediatrics - American Board of Pediatrics
  

Medical Education

• MBBS - Maulana Azad Medical College
  New Delhi
  1999
  

Residency/Fellowship

• Residency - New York Medical College
  Valhalla, NY
  2010
  
• Fellowship - National Institutes of Health
  Bethesda, MD
  2013
  
• Fellowship - National Institutes of Health
  Bethesda, MD
  2012
  

Contact Information

Primary Location:

Childrens Minnesota Genetics
2545 Chicago Ave S STE 700
Minneapolis, MN 55404
(612) 813-7240

Secondary Location(s):

Childrens Minnesota Down Syndrome Clinic
2525 Chicago Ave S CSC 390
Minneapolis, MN 55404
(612)813-6777

Childrens Minnesota Down Syndrome Clinic
345 N Smith Ave STE 70-302
St Paul, MN 55102
(612)813-6777

Childrens Minnesota Genetics
345 N Smith Ave STE 61-245
St Paul, MN 55102
(612) 813-7240

Personal Biography

Board Certification •Clinical Genetics - American Board of Medical Genetics and Genomics •Medical Biochemical Genetics - American Board of Medical Genetics and Genomics •Pediatrics - American Board of Pediatrics Medical Education •MBBS - Maulana Azad Medical College, New Delhi, India Residency/Fellowship •Residency - New York Medical College, Valhalla, NY •Fellowship - National Institutes of Health, Bethesda, MD •Fellowship - National Institutes of Health, Bethesda, MD Research :Current Projects 2020- Physician Investigator, “Single Patient Expanded Access Use of EPI-743 (Vatiquinone)”PTC Therapeutics, Inc. 2020- Site Principal Investigator, “Cerliponase alfa Observational Study”BioMarin Pharmaceutical, Inc. 2020- Site Principal Investigator, “LAL Deficiency Registry”BioMarin Pharmaceutical, Inc. 2019- Site Principal Investigator, “MPS VI Clinical Surveillance Program (CSP)”BioMarin Pharmaceutical Inc. 2018- Site Principal Investigator, “Rare Disease Registries: Fabry, Gaucher, MPS I and Pompe”Sanofi Genzyme 2015- Site Principal Investigator, “Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients with Hunter Syndrome (MPS II)”Shire Human Genetic Therapies, Inc. 2015- Site Principal Investigator, “Gaucher Disease Outcome Survey (GOS)” Shire Human Genetic Therapies, Inc. 2014- Site Principal Investigator, “Morquio A Registry Study (MARS)”BioMarin Pharmaceutical Inc. Special Interests:Mitochondrial disorder, Leukodystrophy, Refractory epilepsy and Neurotransmitter deficiency.